n-(3-(aminomethyl)benzyl)acetamidine has been researched along with arl 17477 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auguet, M; Chabrier, PE; Demerlé-Pallardy, C | 1 |
Bonnefont-Rousselot, D; Jafarian-Tehrani, M; Lerouet, D; Louin, G; Margaill, I; Palmier, B; Plotkine, M | 1 |
1 review(s) available for n-(3-(aminomethyl)benzyl)acetamidine and arl 17477
Article | Year |
---|---|
Nitric oxide synthases: targets for therapeutic strategies in neurological diseases.
Topics: Alzheimer Disease; Amidines; Amyotrophic Lateral Sclerosis; Animals; Benzylamines; Brain Injuries; Brain Ischemia; Enzyme Induction; Humans; Huntington Disease; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Nerve Degeneration; Nerve Tissue Proteins; Nervous System Diseases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Organ Specificity; Polymethacrylic Acids; Pyrazines; Thiophenes | 1999 |
1 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and arl 17477
Article | Year |
---|---|
Lack of iNOS induction in a severe model of transient focal cerebral ischemia in rats.
Topics: Amidines; Analysis of Variance; Animals; Anticoagulants; Benzylamines; Blotting, Western; Brain; Calcium; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Edetic Acid; Enzyme Inhibitors; Inhibitory Concentration 50; Ischemic Attack, Transient; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Time Factors | 2005 |